BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21244239)

  • 1. Grape seed extract regulates androgen receptor-mediated transcription in prostate cancer cells through potent anti-histone acetyltransferase activity.
    Park SY; Lee YH; Choi KC; Seong AR; Choi HK; Lee OH; Hwang HJ; Yoon HG
    J Med Food; 2011; 14(1-2):9-16. PubMed ID: 21244239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
    Choi KC; Park S; Lim BJ; Seong AR; Lee YH; Shiota M; Yokomizo A; Naito S; Na Y; Yoon HG
    Biochem J; 2011 Jan; 433(1):235-44. PubMed ID: 20955177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity.
    Lee YH; Kwak J; Choi HK; Choi KC; Kim S; Lee J; Jun W; Park HJ; Yoon HG
    Int J Mol Med; 2012 Jul; 30(1):69-74. PubMed ID: 22505206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-histone acetyltransferase activity from Rosa rugosa Thunb. (Rosaceae) extracts on androgen receptor-mediated transcriptional regulation.
    Lee YH; Jung MG; Kang HB; Choi KC; Haam S; Jun W; Kim YJ; Cho HY; Yoon HG
    J Ethnopharmacol; 2008 Aug; 118(3):412-7. PubMed ID: 18562138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth.
    Lee YH; Hong SW; Jun W; Cho HY; Kim HC; Jung MG; Wong J; Kim HI; Kim CH; Yoon HG
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2712-9. PubMed ID: 17986787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFkappaB-dependent regulation of urokinase plasminogen activator by proanthocyanidin-rich grape seed extract: effect on invasion by prostate cancer cells.
    Uchino R; Madhyastha R; Madhyastha H; Dhungana S; Nakajima Y; Omura S; Maruyama M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):528-33. PubMed ID: 20502321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAT8 Regulates Androgen Signaling in Prostate Cancer Cells.
    Kim JY; Yu J; Abdulkadir SA; Chakravarti D
    Mol Endocrinol; 2016 Aug; 30(8):925-36. PubMed ID: 27268279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer.
    Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ
    Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells.
    Tyagi A; Kumar S; Raina K; Wempe MF; Maroni PD; Agarwal R; Agarwal C
    Mol Carcinog; 2019 Jul; 58(7):1105-1117. PubMed ID: 30828884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A designed cell-permeable aptamer-based corepressor peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode.
    Reeb CA; Gerlach C; Heinssmann M; Prade I; Ceraline J; Roediger J; Roell D; Baniahmad A
    Endocrinology; 2011 Jun; 152(6):2174-83. PubMed ID: 21486935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells.
    Yeap BB; Krueger RG; Leedman PJ
    Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
    Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.
    Wafa LA; Cheng H; Plaa N; Ghaidi F; Fukumoto T; Fazli L; Gleave ME; Cox ME; Rennie PS
    Int J Cancer; 2012 Jun; 130(12):2835-44. PubMed ID: 21780103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.
    Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H
    Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.